These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
856 related articles for article (PubMed ID: 8774139)
21. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis. Kondo E; Yoshino T Pathol Int; 2007 Jul; 57(7):391-7. PubMed ID: 17587238 [TBL] [Abstract][Full Text] [Related]
22. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998 [TBL] [Abstract][Full Text] [Related]
23. [Apoptosis-antagonizing protein Bcl-2 expression, distribution in non-Hodgkin's lymphoma and its clinical significance]. Chen X; Huang G; Wang W Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):140-2. PubMed ID: 10743081 [TBL] [Abstract][Full Text] [Related]
24. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma. Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431 [TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946 [TBL] [Abstract][Full Text] [Related]
27. Large B-cell lymphoma with Hodgkin's features. García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329 [TBL] [Abstract][Full Text] [Related]
28. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas. Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554 [TBL] [Abstract][Full Text] [Related]
29. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Gustmann C; Altmannsberger M; Osborn M; Griesser H; Feller AC Am J Pathol; 1991 Jun; 138(6):1413-22. PubMed ID: 1711289 [TBL] [Abstract][Full Text] [Related]
30. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024 [TBL] [Abstract][Full Text] [Related]
31. Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation. van Houdt IS; Muris JJ; Hesselink AT; Kramer D; Cillessen SA; Moesbergen LM; Vos W; Hooijberg E; Meijer CJ; Kummer JA; Oudejans JJ Histopathology; 2007 Dec; 51(6):778-84. PubMed ID: 18042067 [TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases. Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599 [TBL] [Abstract][Full Text] [Related]
35. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. van den Berg A; Visser L; Poppema S Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793 [TBL] [Abstract][Full Text] [Related]
36. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487 [TBL] [Abstract][Full Text] [Related]
38. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. Pittaluga S; Ayoubi TA; Wlodarska I; Stul M; Cassiman JJ; Mecucci C; Van Den Berghe H; Van De Ven WJ; De Wolf-Peeters C J Pathol; 1996 Jun; 179(2):145-50. PubMed ID: 8758205 [TBL] [Abstract][Full Text] [Related]
39. Pattern of malignant lymphomas in Rwanda. Ngendahayo P; Schmauz R Bull Cancer; 1992; 79(11):1087-96. PubMed ID: 1302535 [TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma]. Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]